Kim Robert Young (CIK 0001971608)

Latest company ownership

Role: Chief Medical Officer
Shares held
6,000
Last filed at
Feb 7, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 5, 2024 Feb 7, 2024 4D Molecular Therapeutics, Inc. Chief Medical Officer Sell 7.5 -24,552 -80.82% $737.8K